WL5-25537-82380
4 vaccinations
5 coded responses
22 check-ins
5 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 640 / MO
- Registered
- 2021-11-23
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
63W-17332-63484
Child or adolescent in my care · Female · 2021-11-23
FQA-72824-61794
Child or adolescent in my care · Male · 2022-07-03
HUE-47212-68563
Child or adolescent in my care · Male · 2022-07-03
Timeline
-
2021-04-13
Dose 1 — Pfizer-BioNTech
-
2021-05-03
Dose 2 — Pfizer-BioNTech
-
2021-11-21
Dose 3 — Pfizer-BioNTech
-
2021-11-23
Registered in v-safe
-
2021-11-23
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Heart palpitationsAdult check-in · check-in free text available
-
2021-11-25
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Swelling, Itching · Fatigue or tirednessAdult check-in
- 2021-11-26
- 2021-11-27
-
2021-11-28
Survey response — day 7, dose 3MedDRA: Dizziness — Feeling: Fair · Headache · Be unable to do your normal daily activitiesFree text: DizzinessMedDRA releases: 2024-11 · check-in free text available
- 2021-12-05
-
2021-12-13
Survey response — day 21, dose 3MedDRA: Cough, Rhinorrhoea, Sneezing — Feeling: FairFree text: Cough, sneezing, runny noseMedDRA releases: 2024-11 · check-in free text available
- 2021-12-19
-
2021-12-26
Survey response — day 35, dose 3MedDRA: Rhinorrhoea, Sneezing — Feeling: FairFree text: Sneezing, runny noseMedDRA releases: 2024-11 · check-in free text available
- 2022-01-02
- 2022-02-20
- 2022-05-22
-
2022-11-17
Dose 4 — Moderna
- 2022-11-21
- 2022-11-22
- 2022-11-23
- 2022-11-24
- 2022-12-01
- 2022-12-15
- 2022-12-22
-
2022-12-29
Survey response — day 42, dose 4MedDRA: Anaemia, Dyspnoea, Pregnancy — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Anemia and breathlessness related to pregnancyMedDRA releases: 2024-11 · check-in free text available
-
2023-02-16
Survey response — 3 months, dose 4MedDRA: Pregnancy — Feeling: Fair · Be unable to do your normal daily activitiesMedDRA releases: 2024-11
- 2023-05-18
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-13 | Pfizer-BioNTech | No |
| 2 | 2021-05-03 | Pfizer-BioNTech | No |
| 3 | 2021-11-21 | Pfizer-BioNTech | No |
| 4 | 2022-11-17 | Moderna | No |
Free text
Release 10 — day 7, dose 3
Systemic reaction (other): Dizziness
Release 10 — day 21, dose 3
Symptoms: Cough, sneezing, runny nose
Release 10 — day 35, dose 3
Symptoms: Sneezing, runny nose
Release 12 — days 1–6 daily, dose 3
Systemic reaction (other): Heart palpitations
Release 12 — day 42, dose 4
Symptoms: Anemia and breathlessness related to pregnancy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Anaemia | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
| SRO | Dizziness | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release